Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

AMGEN

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 30
  • 0 comments

FDA approve DENOSUMAB

Comment Full text

AVANTHI INC

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 37
  • 0 comments

FDA approve DEXTROAMPHETAMINE SULFATE

Comment Full text

AMNEAL

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 27
  • 0 comments

FDA approve FOSCARNET SODIUM

Comment Full text

HETERO LABS LTD V

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 39
  • 0 comments

FDA approve CAPECITABINE

Comment Full text

HOSPIRA

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 35
  • 0 comments

FDA approve KETOROLAC TROMETHAMINE

Comment Full text

CARNEGIE

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 34
  • 0 comments

FDA approve OXCARBAZEPINE

Comment Full text

BRISTOL MYERS SQUIBB

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 39
  • 0 comments

FDA approve NIVOLUMAB

Comment Full text

HERON THERAPS INC

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 40
  • 0 comments

FDA approve APREPITANT

Comment Full text

SANDOZ INC

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 33
  • 0 comments

FDA approve RIFAXIMIN

Comment Full text

ZYDUS PHARMS USA INC

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 49
  • 0 comments

FDA approve EMPAGLIFLOZIN;LINAGLIPTIN;METFORMIN HYDROCHLORIDE

Comment Full text
  • Previous
  • 516
  • 517
  • 518
  • 519
  • 520
  • Next

Search

News categories

  • Technical Exchange News(14694)
  • Event(6229)
  • SEC News(393628)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(239533)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin